|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
05/10/2018 |
$2.30 |
$2.32 |
$2.27 |
$2.27 |
10.70K | 05/11/2018 |
$2.27 |
$2.30 |
$2.25 |
$2.27 |
80.60K | 05/14/2018 |
$2.27 |
$2.38 |
$2.26 |
$2.38 |
115.40K | 05/15/2018 |
$2.37 |
$2.40 |
$2.34 |
$2.38 |
57.20K | 05/16/2018 |
$2.40 |
$2.45 |
$2.30 |
$2.33 |
90.40K |
|
Correvio Pharma is engaged in the discovery, development and commercialization of drugs to treat or prevent cardiovascular diseases. Co.'s product, BRINAVESS, is approved for marketing in the European Union, Iceland and Norway for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. Co.'s clinical programs are also focused on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart. Co. also has a few pre-clinical projects directed at various therapeutic indications that focus on modulating cellular proteins (ion channels) for cardiac diseases. | |
|
CRME (CRME) has the following price history information. Looking back at CRME historical stock prices for the last five trading days, on May 10, 2018, CRME opened at $2.30, traded as high as $2.32 and as low as $2.27, and closed at $2.27. Trading volume was a total of 10.70K shares. On May 11, 2018, CRME opened at $2.27, traded as high as $2.30 and as low as $2.25, and closed at $2.27. Trading volume was a total of 80.60K shares. On May 14, 2018, CRME opened at $2.27, traded as high as $2.38 and as low as $2.26, and closed at $2.38. Trading volume was a total of 115.40K shares. On May 15, 2018, CRME opened at $2.37, traded as high as $2.40 and as low as $2.34, and closed at $2.38. Trading volume was a total of 57.20K shares. On May 16, 2018, CRME opened at $2.40, traded as high as $2.45 and as low as $2.30, and closed at $2.33. Trading volume was a total of 90.40K shares.
CRME Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CRME shares, starting with a $10,000 purchase of CRME, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
05/16/2018 |
|
Start price/share: |
$7.60 |
|
End price/share: |
$2.33 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-69.34% |
|
Average Annual Total Return: |
-25.26% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,066.13 |
|
Years: |
4.06 |
|
|
|
Date |
Close |
05/10/2018 | $2.27 | 05/11/2018 | $2.27 | 05/14/2018 | $2.38 | 05/15/2018 | $2.38 | 05/16/2018 | $2.33 |
|
|